

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.93829513 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.80847046 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.59075985 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.45652884 |
| 5 | glutamate secretion (GO:0014047) | 5.16836314 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.14813979 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.10823774 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.10149564 |
| 9 | vocalization behavior (GO:0071625) | 5.01212442 |
| 10 | glycosphingolipid catabolic process (GO:0046479) | 4.97267128 |
| 11 | locomotory exploration behavior (GO:0035641) | 4.93093653 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.86140621 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.69133058 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.59689769 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.52305608 |
| 16 | glycolipid catabolic process (GO:0019377) | 4.44212263 |
| 17 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.42138697 |
| 18 | barbed-end actin filament capping (GO:0051016) | 4.36570150 |
| 19 | protein localization to synapse (GO:0035418) | 4.29703890 |
| 20 | amino sugar catabolic process (GO:0046348) | 4.19127719 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.18415526 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.09371812 |
| 23 | oligosaccharide catabolic process (GO:0009313) | 4.07656424 |
| 24 | regulation of synapse structural plasticity (GO:0051823) | 4.03070131 |
| 25 | regulation of mononuclear cell migration (GO:0071675) | 4.01784747 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.99413471 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 3.96691069 |
| 28 | ceramide catabolic process (GO:0046514) | 3.94951567 |
| 29 | neuronal action potential propagation (GO:0019227) | 3.93432324 |
| 30 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.92946230 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 3.76448437 |
| 32 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.76295627 |
| 33 | transferrin transport (GO:0033572) | 3.74996233 |
| 34 | exploration behavior (GO:0035640) | 3.74236005 |
| 35 | proline transport (GO:0015824) | 3.72089426 |
| 36 | neuron-neuron synaptic transmission (GO:0007270) | 3.69773055 |
| 37 | regulation of cholesterol storage (GO:0010885) | 3.66240382 |
| 38 | long-term synaptic potentiation (GO:0060291) | 3.64485357 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.57250788 |
| 40 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.56959657 |
| 41 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.56446336 |
| 42 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.56446336 |
| 43 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.54703037 |
| 44 | glutamate receptor signaling pathway (GO:0007215) | 3.53690406 |
| 45 | positive regulation of membrane potential (GO:0045838) | 3.53488453 |
| 46 | positive regulation of neurotransmitter transport (GO:0051590) | 3.52566739 |
| 47 | protein localization to endosome (GO:0036010) | 3.48552404 |
| 48 | trivalent inorganic cation transport (GO:0072512) | 3.44913560 |
| 49 | ferric iron transport (GO:0015682) | 3.44913560 |
| 50 | regulation of synaptic plasticity (GO:0048167) | 3.44508995 |
| 51 | membrane lipid catabolic process (GO:0046466) | 3.43819821 |
| 52 | sphingolipid catabolic process (GO:0030149) | 3.38940361 |
| 53 | response to histamine (GO:0034776) | 3.38810530 |
| 54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.37400946 |
| 55 | virion attachment to host cell (GO:0019062) | 3.36935972 |
| 56 | adhesion of symbiont to host cell (GO:0044650) | 3.36935972 |
| 57 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.35250584 |
| 58 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.33124984 |
| 59 | long-term memory (GO:0007616) | 3.32811441 |
| 60 | regulation of neurotransmitter secretion (GO:0046928) | 3.30654332 |
| 61 | activation of protein kinase A activity (GO:0034199) | 3.30299059 |
| 62 | response to auditory stimulus (GO:0010996) | 3.30074829 |
| 63 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.28988186 |
| 64 | neurotransmitter transport (GO:0006836) | 3.27499250 |
| 65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.27357995 |
| 66 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.24821881 |
| 67 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.24644452 |
| 68 | negative regulation of amino acid transport (GO:0051956) | 3.23214566 |
| 69 | synaptic vesicle endocytosis (GO:0048488) | 3.22819199 |
| 70 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.21221104 |
| 71 | postsynaptic membrane organization (GO:0001941) | 3.19589380 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 3.18100034 |
| 73 | cellular potassium ion homeostasis (GO:0030007) | 3.18028509 |
| 74 | phagosome maturation (GO:0090382) | 3.17845012 |
| 75 | neuromuscular process controlling posture (GO:0050884) | 3.17603297 |
| 76 | positive regulation of synapse maturation (GO:0090129) | 3.16624771 |
| 77 | positive regulation of synaptic transmission (GO:0050806) | 3.14035161 |
| 78 | adhesion of symbiont to host (GO:0044406) | 3.12724080 |
| 79 | regulation of glutamate secretion (GO:0014048) | 3.12699920 |
| 80 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.09501068 |
| 81 | regulation of neurotransmitter levels (GO:0001505) | 3.08600999 |
| 82 | regulation of vesicle fusion (GO:0031338) | 3.08309494 |
| 83 | regulation of neurotransmitter transport (GO:0051588) | 3.07887976 |
| 84 | response to acidic pH (GO:0010447) | 3.05879391 |
| 85 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.05596567 |
| 86 | glial cell migration (GO:0008347) | 3.05481518 |
| 87 | apoptotic cell clearance (GO:0043277) | 3.05149421 |
| 88 | keratan sulfate catabolic process (GO:0042340) | 3.04956506 |
| 89 | presynaptic membrane assembly (GO:0097105) | 3.01713252 |
| 90 | gamma-aminobutyric acid transport (GO:0015812) | 3.01283721 |
| 91 | auditory behavior (GO:0031223) | 3.00828961 |
| 92 | response to peptidoglycan (GO:0032494) | 2.96469499 |
| 93 | regulation of female receptivity (GO:0045924) | 2.94587455 |
| 94 | mannose metabolic process (GO:0006013) | 2.92845610 |
| 95 | neuromuscular process controlling balance (GO:0050885) | 2.92345824 |
| 96 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91389058 |
| 97 | ganglioside metabolic process (GO:0001573) | 2.90465744 |
| 98 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.89067096 |
| 99 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.88268815 |
| 100 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.86162684 |
| 101 | adenosine receptor signaling pathway (GO:0001973) | 2.86107131 |
| 102 | membrane depolarization (GO:0051899) | 2.85273457 |
| 103 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.85159957 |
| 104 | regulation of synaptic transmission (GO:0050804) | 2.84911294 |
| 105 | response to thyroid hormone (GO:0097066) | 2.82553749 |
| 106 | positive regulation of cholesterol efflux (GO:0010875) | 2.79521895 |
| 107 | female mating behavior (GO:0060180) | 2.79210973 |
| 108 | behavioral response to cocaine (GO:0048148) | 2.78151487 |
| 109 | layer formation in cerebral cortex (GO:0021819) | 2.77940490 |
| 110 | presynaptic membrane organization (GO:0097090) | 2.77889506 |
| 111 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.76815306 |
| 112 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.75234266 |
| 113 | N-acetylneuraminate metabolic process (GO:0006054) | 2.74944046 |
| 114 | synaptic transmission (GO:0007268) | 2.74732973 |
| 115 | sodium ion export (GO:0071436) | 2.74079870 |
| 116 | positive regulation of heat generation (GO:0031652) | 2.73899896 |
| 117 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.72484537 |
| 118 | membrane depolarization during action potential (GO:0086010) | 2.70967501 |
| 119 | positive regulation of vesicle fusion (GO:0031340) | 2.70774910 |
| 120 | regulation of exocytosis (GO:0017157) | 2.70684719 |
| 121 | regulation of macrophage chemotaxis (GO:0010758) | 2.70680973 |
| 122 | vesicle transport along microtubule (GO:0047496) | 2.70524442 |
| 123 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.70120250 |
| 124 | mechanosensory behavior (GO:0007638) | 2.69719781 |
| 125 | dendritic spine morphogenesis (GO:0060997) | 2.69215362 |
| 126 | establishment of synaptic vesicle localization (GO:0097480) | 2.68983013 |
| 127 | synaptic vesicle transport (GO:0048489) | 2.68983013 |
| 128 | cerebellar Purkinje cell layer development (GO:0021680) | 2.66742539 |
| 129 | learning (GO:0007612) | 2.66532211 |
| 130 | neuron recognition (GO:0008038) | 2.64283393 |
| 131 | membrane hyperpolarization (GO:0060081) | 2.63949986 |
| 132 | protein retention in ER lumen (GO:0006621) | 2.63688101 |
| 133 | calcium ion-dependent exocytosis (GO:0017156) | 2.63510562 |
| 134 | L-amino acid import (GO:0043092) | 2.62580282 |
| 135 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.61606715 |
| 136 | positive regulation of leukocyte degranulation (GO:0043302) | 2.60973305 |
| 137 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.59773367 |
| 138 | cell-cell junction maintenance (GO:0045217) | 2.57847964 |
| 139 | low-density lipoprotein particle clearance (GO:0034383) | 2.57383885 |
| 140 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.56866315 |
| 141 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.54538924 |
| 142 | amyloid precursor protein catabolic process (GO:0042987) | 2.54221317 |
| 143 | lytic vacuole organization (GO:0080171) | 2.51521199 |
| 144 | lysosome organization (GO:0007040) | 2.51521199 |
| 145 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.51120596 |
| 146 | regulation of fever generation (GO:0031620) | 2.50228218 |
| 147 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.49791426 |
| 148 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.49254896 |
| 149 | decidualization (GO:0046697) | 2.49143929 |
| 150 | regulation of early endosome to late endosome transport (GO:2000641) | 2.48796748 |
| 151 | neutrophil activation involved in immune response (GO:0002283) | 2.48285387 |
| 152 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.47822543 |
| 153 | regulation of podosome assembly (GO:0071801) | 2.47549310 |
| 154 | response to manganese ion (GO:0010042) | 2.46184138 |
| 155 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.44824390 |
| 156 | COPI coating of Golgi vesicle (GO:0048205) | 2.43132010 |
| 157 | Golgi transport vesicle coating (GO:0048200) | 2.43132010 |
| 158 | monocyte chemotaxis (GO:0002548) | 2.43026617 |
| 159 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.41011920 |
| 160 | glucose 6-phosphate metabolic process (GO:0051156) | 2.40094024 |
| 161 | bone resorption (GO:0045453) | 2.39410718 |
| 162 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.39241790 |
| 163 | regulation of leukocyte degranulation (GO:0043300) | 2.38869987 |
| 164 | activation of MAPKKK activity (GO:0000185) | 2.36848587 |
| 165 | regulation of monocyte chemotaxis (GO:0090025) | 2.34791741 |
| 166 | positive regulation of mast cell degranulation (GO:0043306) | 2.32858995 |
| 167 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.32858995 |
| 168 | stress fiber assembly (GO:0043149) | 2.31957143 |
| 169 | macrophage activation involved in immune response (GO:0002281) | 2.31952921 |
| 170 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.31622712 |
| 171 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.31132366 |
| 172 | chondroitin sulfate catabolic process (GO:0030207) | 2.30104792 |
| 173 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.28264747 |
| 174 | regulation of mast cell degranulation (GO:0043304) | 2.28044207 |
| 175 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.24862849 |
| 176 | serine transport (GO:0032329) | 2.24749777 |
| 177 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.22343159 |
| 178 | cellular copper ion homeostasis (GO:0006878) | 2.22337555 |
| 179 | positive regulation of sterol transport (GO:0032373) | 2.22314547 |
| 180 | positive regulation of cholesterol transport (GO:0032376) | 2.22314547 |
| 181 | eosinophil chemotaxis (GO:0048245) | 2.21683535 |
| 182 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.21339577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.91140175 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.53484802 |
| 3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.28223719 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10183122 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00073041 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.95146332 |
| 7 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.84591913 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.75947439 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74248121 |
| 10 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.71095479 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.70184532 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.66940747 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.59887936 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55897999 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49318732 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.49003425 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.49003425 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46476377 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45981311 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44686518 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44251550 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.43542281 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.33202703 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13419065 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11692892 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.10185006 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.09871782 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07583020 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.02409759 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99212764 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94502253 |
| 32 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.92908550 |
| 33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.90647026 |
| 34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.87224358 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.83019494 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82692475 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.81962080 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80712352 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.76054283 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.75537653 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70562438 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70212834 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68889838 |
| 44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.64148239 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63867281 |
| 46 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62942914 |
| 47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62683024 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59942961 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59078730 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58824627 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57498249 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.55272767 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53872214 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53734368 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53322625 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.48954218 |
| 57 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48062906 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47342861 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46202101 |
| 60 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39796761 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39576851 |
| 62 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.39473043 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37911761 |
| 64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37680053 |
| 65 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35690250 |
| 66 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35646972 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34698228 |
| 68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34320179 |
| 69 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33003052 |
| 70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30982982 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27383212 |
| 72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26995960 |
| 73 | P300_19829295_ChIP-Seq_ESCs_Human | 1.26425713 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25730124 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25514281 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24265010 |
| 77 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23665216 |
| 78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22806956 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22562856 |
| 80 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22439698 |
| 81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22183570 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20888486 |
| 83 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20532118 |
| 84 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19017183 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18447908 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18439256 |
| 87 | P68_20966046_ChIP-Seq_HELA_Human | 1.17767524 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17124167 |
| 89 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16207575 |
| 90 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14783639 |
| 91 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13062878 |
| 92 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12979743 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12574261 |
| 94 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12331893 |
| 95 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12094143 |
| 96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10905752 |
| 97 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09793767 |
| 98 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09558882 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09380334 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09095895 |
| 101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08672744 |
| 102 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08342664 |
| 103 | AR_19668381_ChIP-Seq_PC3_Human | 1.07990810 |
| 104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07751729 |
| 105 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07285374 |
| 106 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07005623 |
| 107 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06610518 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06542830 |
| 109 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.06341189 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05594817 |
| 111 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05400411 |
| 112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05351376 |
| 113 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04932047 |
| 114 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04592275 |
| 115 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04375008 |
| 116 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04194845 |
| 117 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04089644 |
| 118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03768065 |
| 119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03681962 |
| 120 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02715288 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01650514 |
| 122 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01618851 |
| 123 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.01099215 |
| 124 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99916788 |
| 125 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99796965 |
| 126 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99548414 |
| 127 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99349540 |
| 128 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99220570 |
| 129 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99160431 |
| 130 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98714277 |
| 131 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98617655 |
| 132 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98341671 |
| 133 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98331266 |
| 134 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97744407 |
| 135 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96966391 |
| 136 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96444654 |
| 137 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95822837 |
| 138 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.94749053 |
| 139 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94556031 |
| 140 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94459227 |
| 141 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94345472 |
| 142 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94175757 |
| 143 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94105788 |
| 144 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91968153 |
| 145 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91535856 |
| 146 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90960716 |
| 147 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87880398 |
| 148 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86317081 |
| 149 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84143624 |
| 150 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83593141 |
| 151 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.82942538 |
| 152 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82512615 |
| 153 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82512052 |
| 154 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.82345823 |
| 155 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81256543 |
| 156 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80848611 |
| 157 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80734321 |
| 158 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80734321 |
| 159 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.80302832 |
| 160 | JUN_21703547_ChIP-Seq_K562_Human | 0.79494391 |
| 161 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.79166168 |
| 162 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76043213 |
| 163 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75922873 |
| 164 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.74843188 |
| 165 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.74791394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.39086350 |
| 2 | MP0003880_abnormal_central_pattern | 4.66911037 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.99508726 |
| 4 | MP0009840_abnormal_foam_cell | 3.98349284 |
| 5 | MP0009745_abnormal_behavioral_response | 3.38017741 |
| 6 | MP0002064_seizures | 3.37357991 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.24022671 |
| 8 | MP0009046_muscle_twitch | 3.18587651 |
| 9 | MP0002822_catalepsy | 3.17580016 |
| 10 | MP0004270_analgesia | 3.17377899 |
| 11 | MP0001968_abnormal_touch/_nociception | 3.10593429 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.78516567 |
| 13 | MP0002736_abnormal_nociception_after | 2.66904043 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.51580374 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.39804006 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.39404661 |
| 17 | MP0000343_altered_response_to | 2.38529687 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.31545807 |
| 19 | MP0002272_abnormal_nervous_system | 2.30293746 |
| 20 | MP0001486_abnormal_startle_reflex | 2.14179680 |
| 21 | MP0003436_decreased_susceptibility_to | 2.09752325 |
| 22 | MP0003879_abnormal_hair_cell | 2.09315214 |
| 23 | MP0009278_abnormal_bone_marrow | 2.08921835 |
| 24 | MP0002735_abnormal_chemical_nociception | 2.07820582 |
| 25 | MP0004858_abnormal_nervous_system | 2.05826768 |
| 26 | MP0002909_abnormal_adrenal_gland | 1.96736005 |
| 27 | MP0005423_abnormal_somatic_nervous | 1.96348349 |
| 28 | MP0001440_abnormal_grooming_behavior | 1.95545065 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.93387488 |
| 30 | MP0001970_abnormal_pain_threshold | 1.90780421 |
| 31 | MP0005257_abnormal_intraocular_pressure | 1.89841256 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.88989965 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.88670046 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.86806284 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.85239426 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.83648424 |
| 37 | MP0003329_amyloid_beta_deposits | 1.80898362 |
| 38 | MP0002254_reproductive_system_inflammat | 1.78936723 |
| 39 | MP0002067_abnormal_sensory_capabilities | 1.77285288 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.74659393 |
| 41 | MP0008569_lethality_at_weaning | 1.69789213 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.65505952 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.65502254 |
| 44 | MP0003279_aneurysm | 1.59988835 |
| 45 | MP0003724_increased_susceptibility_to | 1.59213561 |
| 46 | MP0006054_spinal_hemorrhage | 1.58603098 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.56782460 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.55786963 |
| 49 | MP0004924_abnormal_behavior | 1.55666284 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.55666284 |
| 51 | MP0003633_abnormal_nervous_system | 1.55427087 |
| 52 | MP0003075_altered_response_to | 1.54817095 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.52476363 |
| 54 | MP0005451_abnormal_body_composition | 1.51477926 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.46677136 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.42471857 |
| 57 | MP0009764_decreased_sensitivity_to | 1.41827815 |
| 58 | MP0003690_abnormal_glial_cell | 1.40615690 |
| 59 | MP0009785_altered_susceptibility_to | 1.39650894 |
| 60 | MP0003122_maternal_imprinting | 1.39100413 |
| 61 | MP0000604_amyloidosis | 1.38903913 |
| 62 | MP0001542_abnormal_bone_strength | 1.34273375 |
| 63 | MP0004510_myositis | 1.32378164 |
| 64 | MP0002184_abnormal_innervation | 1.32314266 |
| 65 | MP0003787_abnormal_imprinting | 1.31713514 |
| 66 | MP0001502_abnormal_circadian_rhythm | 1.28617009 |
| 67 | MP0001529_abnormal_vocalization | 1.26901144 |
| 68 | MP0002066_abnormal_motor_capabilities/c | 1.24209935 |
| 69 | MP0001984_abnormal_olfaction | 1.23804769 |
| 70 | MP0006276_abnormal_autonomic_nervous | 1.21631598 |
| 71 | MP0005025_abnormal_response_to | 1.21170487 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.20454752 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.18193630 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.18193630 |
| 75 | MP0001905_abnormal_dopamine_level | 1.18005918 |
| 76 | MP0002090_abnormal_vision | 1.17437369 |
| 77 | MP0003631_nervous_system_phenotype | 1.14618659 |
| 78 | MP0001958_emphysema | 1.13068923 |
| 79 | MP0001849_ear_inflammation | 1.12513089 |
| 80 | MP0005000_abnormal_immune_tolerance | 1.11582025 |
| 81 | MP0000955_abnormal_spinal_cord | 1.10606766 |
| 82 | MP0003303_peritoneal_inflammation | 1.09061052 |
| 83 | MP0002882_abnormal_neuron_morphology | 1.09057486 |
| 84 | MP0003705_abnormal_hypodermis_morpholog | 1.08787701 |
| 85 | MP0003448_altered_tumor_morphology | 1.07292833 |
| 86 | MP0000858_altered_metastatic_potential | 1.06822222 |
| 87 | MP0000569_abnormal_digit_pigmentation | 1.05144363 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 1.04034403 |
| 89 | MP0008961_abnormal_basal_metabolism | 1.02967861 |
| 90 | MP0000778_abnormal_nervous_system | 1.01135476 |
| 91 | MP0001853_heart_inflammation | 1.00969941 |
| 92 | MP0003091_abnormal_cell_migration | 1.00333297 |
| 93 | MP0005310_abnormal_salivary_gland | 0.98065272 |
| 94 | MP0001790_abnormal_immune_system | 0.96886615 |
| 95 | MP0005387_immune_system_phenotype | 0.96886615 |
| 96 | MP0005535_abnormal_body_temperature | 0.96782047 |
| 97 | MP0008874_decreased_physiological_sensi | 0.96754050 |
| 98 | MP0005595_abnormal_vascular_smooth | 0.96735495 |
| 99 | MP0004142_abnormal_muscle_tone | 0.95452157 |
| 100 | MP0003634_abnormal_glial_cell | 0.94922176 |
| 101 | MP0008872_abnormal_physiological_respon | 0.94645393 |
| 102 | MP0005390_skeleton_phenotype | 0.94463730 |
| 103 | MP0002653_abnormal_ependyma_morphology | 0.94044312 |
| 104 | MP0002069_abnormal_eating/drinking_beha | 0.92267700 |
| 105 | MP0005165_increased_susceptibility_to | 0.91858041 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.91273908 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 0.91227240 |
| 108 | MP0004947_skin_inflammation | 0.91199599 |
| 109 | MP0005166_decreased_susceptibility_to | 0.89985178 |
| 110 | MP0002896_abnormal_bone_mineralization | 0.89067956 |
| 111 | MP0000747_muscle_weakness | 0.88489448 |
| 112 | MP0008469_abnormal_protein_level | 0.87736901 |
| 113 | MP0008004_abnormal_stomach_pH | 0.87404551 |
| 114 | MP0002229_neurodegeneration | 0.84860980 |
| 115 | MP0002332_abnormal_exercise_endurance | 0.81224916 |
| 116 | MP0000751_myopathy | 0.79755320 |
| 117 | MP0002452_abnormal_antigen_presenting | 0.79358121 |
| 118 | MP0001845_abnormal_inflammatory_respons | 0.78436029 |
| 119 | MP0006082_CNS_inflammation | 0.76617844 |
| 120 | MP0000750_abnormal_muscle_regeneration | 0.76527382 |
| 121 | MP0005671_abnormal_response_to | 0.75211042 |
| 122 | MP0001664_abnormal_digestion | 0.75031963 |
| 123 | MP0001177_atelectasis | 0.74479118 |
| 124 | MP0000920_abnormal_myelination | 0.73221194 |
| 125 | MP0003795_abnormal_bone_structure | 0.71612609 |
| 126 | MP0005464_abnormal_platelet_physiology | 0.70353032 |
| 127 | MP0004885_abnormal_endolymph | 0.70220794 |
| 128 | MP0002152_abnormal_brain_morphology | 0.69853750 |
| 129 | MP0005508_abnormal_skeleton_morphology | 0.68874290 |
| 130 | MP0002723_abnormal_immune_serum | 0.67394954 |
| 131 | MP0001835_abnormal_antigen_presentation | 0.65481005 |
| 132 | MP0003632_abnormal_nervous_system | 0.62026578 |
| 133 | MP0003566_abnormal_cell_adhesion | 0.61064036 |
| 134 | MP0001963_abnormal_hearing_physiology | 0.60229966 |
| 135 | MP0004085_abnormal_heartbeat | 0.59887074 |
| 136 | MP0004130_abnormal_muscle_cell | 0.58876403 |
| 137 | MP0008260_abnormal_autophagy | 0.58423936 |
| 138 | MP0002837_dystrophic_cardiac_calcinosis | 0.58348955 |
| 139 | MP0001188_hyperpigmentation | 0.53613696 |
| 140 | MP0004742_abnormal_vestibular_system | 0.52981642 |
| 141 | MP0005448_abnormal_energy_balance | 0.51926328 |
| 142 | MP0004484_altered_response_of | 0.50228958 |
| 143 | MP0002998_abnormal_bone_remodeling | 0.49731227 |
| 144 | MP0005551_abnormal_eye_electrophysiolog | 0.48846017 |
| 145 | MP0003045_fibrosis | 0.46175803 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.45064602 |
| 147 | MP0005623_abnormal_meninges_morphology | 0.43941836 |
| 148 | MP0000681_abnormal_thyroid_gland | 0.41705826 |
| 149 | MP0004043_abnormal_pH_regulation | 0.41514909 |
| 150 | MP0002419_abnormal_innate_immunity | 0.40816389 |
| 151 | MP0004233_abnormal_muscle_weight | 0.40711857 |
| 152 | MP0002148_abnormal_hypersensitivity_rea | 0.40547542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.56205502 |
| 2 | Myokymia (HP:0002411) | 6.27868847 |
| 3 | Focal seizures (HP:0007359) | 5.45835556 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 5.24862247 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.00035854 |
| 6 | Atonic seizures (HP:0010819) | 4.96729964 |
| 7 | Visual hallucinations (HP:0002367) | 4.84416581 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.39244273 |
| 9 | Febrile seizures (HP:0002373) | 4.28021572 |
| 10 | Absence seizures (HP:0002121) | 4.20161250 |
| 11 | Disinhibition (HP:0000734) | 4.16781904 |
| 12 | Dialeptic seizures (HP:0011146) | 3.98198186 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.96492967 |
| 14 | Nuclear cataract (HP:0100018) | 3.82968559 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.76283988 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.76120418 |
| 17 | Axonal loss (HP:0003447) | 3.66413447 |
| 18 | Abnormal eating behavior (HP:0100738) | 3.50408798 |
| 19 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.44245443 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 3.41195876 |
| 21 | Mutism (HP:0002300) | 3.28883309 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.25153030 |
| 23 | Action tremor (HP:0002345) | 3.17525909 |
| 24 | Depression (HP:0000716) | 3.15509484 |
| 25 | Hyperventilation (HP:0002883) | 3.12277534 |
| 26 | Polyphagia (HP:0002591) | 3.11079144 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.06196339 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.06196339 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.06196339 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.98688329 |
| 31 | Ankle clonus (HP:0011448) | 2.97092436 |
| 32 | Broad-based gait (HP:0002136) | 2.96723233 |
| 33 | Poor eye contact (HP:0000817) | 2.92308853 |
| 34 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.91445458 |
| 35 | Abnormality of binocular vision (HP:0011514) | 2.88608896 |
| 36 | Diplopia (HP:0000651) | 2.88608896 |
| 37 | Anxiety (HP:0000739) | 2.88042983 |
| 38 | Postural instability (HP:0002172) | 2.80270265 |
| 39 | Upper motor neuron abnormality (HP:0002127) | 2.78842327 |
| 40 | Gaze-evoked nystagmus (HP:0000640) | 2.76067547 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.75236102 |
| 42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.73278236 |
| 43 | Torticollis (HP:0000473) | 2.70718903 |
| 44 | Amyloidosis (HP:0011034) | 2.66221573 |
| 45 | Abnormal social behavior (HP:0012433) | 2.66218676 |
| 46 | Impaired social interactions (HP:0000735) | 2.66218676 |
| 47 | Truncal ataxia (HP:0002078) | 2.65920478 |
| 48 | Neuronal loss in central nervous system (HP:0002529) | 2.65169510 |
| 49 | Neurofibrillary tangles (HP:0002185) | 2.64504938 |
| 50 | Dysdiadochokinesis (HP:0002075) | 2.62518960 |
| 51 | Vertebral compression fractures (HP:0002953) | 2.62320316 |
| 52 | Failure to thrive in infancy (HP:0001531) | 2.57170393 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 2.56106526 |
| 54 | Progressive neurologic deterioration (HP:0002344) | 2.54888925 |
| 55 | Amblyopia (HP:0000646) | 2.53970860 |
| 56 | Pheochromocytoma (HP:0002666) | 2.50975711 |
| 57 | Dysmetria (HP:0001310) | 2.49510643 |
| 58 | Glomerulonephritis (HP:0000099) | 2.47565105 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.47424880 |
| 60 | Focal dystonia (HP:0004373) | 2.47221133 |
| 61 | Distal upper limb amyotrophy (HP:0007149) | 2.47205958 |
| 62 | Upper limb amyotrophy (HP:0009129) | 2.47205958 |
| 63 | Hand muscle atrophy (HP:0009130) | 2.43902823 |
| 64 | Resting tremor (HP:0002322) | 2.42010148 |
| 65 | Stereotypic behavior (HP:0000733) | 2.39966496 |
| 66 | Papilledema (HP:0001085) | 2.38534336 |
| 67 | Premature rupture of membranes (HP:0001788) | 2.38186536 |
| 68 | Progressive inability to walk (HP:0002505) | 2.37294610 |
| 69 | Agnosia (HP:0010524) | 2.35773963 |
| 70 | Impaired smooth pursuit (HP:0007772) | 2.34689099 |
| 71 | Bradykinesia (HP:0002067) | 2.34669975 |
| 72 | Interstitial pulmonary disease (HP:0006530) | 2.34624022 |
| 73 | Neuroendocrine neoplasm (HP:0100634) | 2.30742487 |
| 74 | Personality changes (HP:0000751) | 2.30344919 |
| 75 | Myocardial infarction (HP:0001658) | 2.28497375 |
| 76 | Abnormality of the lower motor neuron (HP:0002366) | 2.27032349 |
| 77 | Epileptiform EEG discharges (HP:0011182) | 2.24410797 |
| 78 | Cerebral aneurysm (HP:0004944) | 2.23346894 |
| 79 | Asymmetric septal hypertrophy (HP:0001670) | 2.23138070 |
| 80 | Dysmetric saccades (HP:0000641) | 2.22048393 |
| 81 | Craniofacial dystonia (HP:0012179) | 2.20335989 |
| 82 | Abnormal hair whorl (HP:0010721) | 2.17847273 |
| 83 | Status epilepticus (HP:0002133) | 2.17737375 |
| 84 | Complement deficiency (HP:0004431) | 2.16894387 |
| 85 | Drooling (HP:0002307) | 2.14934852 |
| 86 | Excessive salivation (HP:0003781) | 2.14934852 |
| 87 | Prolonged neonatal jaundice (HP:0006579) | 2.14750278 |
| 88 | Agitation (HP:0000713) | 2.13549555 |
| 89 | Purpura (HP:0000979) | 2.11333932 |
| 90 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.10940273 |
| 91 | Hemiplegia (HP:0002301) | 2.10375418 |
| 92 | Spinal canal stenosis (HP:0003416) | 2.10249075 |
| 93 | Loss of speech (HP:0002371) | 2.10127401 |
| 94 | Generalized myoclonic seizures (HP:0002123) | 2.10094149 |
| 95 | Pathologic fracture (HP:0002756) | 2.09182720 |
| 96 | Apathy (HP:0000741) | 2.08507390 |
| 97 | Impaired vibratory sensation (HP:0002495) | 2.08355047 |
| 98 | Mucopolysacchariduria (HP:0008155) | 2.07892239 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.07892239 |
| 100 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.06416678 |
| 101 | Hypoventilation (HP:0002791) | 2.05796582 |
| 102 | Hemiparesis (HP:0001269) | 2.05744351 |
| 103 | Inappropriate behavior (HP:0000719) | 2.05636692 |
| 104 | Retinal atrophy (HP:0001105) | 2.03709766 |
| 105 | Oligomenorrhea (HP:0000876) | 2.03335928 |
| 106 | Inability to walk (HP:0002540) | 2.03314531 |
| 107 | Recurrent bacterial skin infections (HP:0005406) | 2.03253158 |
| 108 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02658997 |
| 109 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02658997 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02658997 |
| 111 | Eczematoid dermatitis (HP:0000976) | 2.02502719 |
| 112 | Urinary urgency (HP:0000012) | 2.02401147 |
| 113 | J-shaped sella turcica (HP:0002680) | 2.01776308 |
| 114 | EEG with generalized epileptiform discharges (HP:0011198) | 2.01463869 |
| 115 | Abnormality of the periventricular white matter (HP:0002518) | 2.01195806 |
| 116 | Recurrent abscess formation (HP:0002722) | 2.00753867 |
| 117 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.99940492 |
| 118 | Dementia (HP:0000726) | 1.98884395 |
| 119 | Psychosis (HP:0000709) | 1.98871773 |
| 120 | Rigidity (HP:0002063) | 1.97812687 |
| 121 | Menstrual irregularities (HP:0000858) | 1.96963461 |
| 122 | Genetic anticipation (HP:0003743) | 1.95407604 |
| 123 | Autoimmune thrombocytopenia (HP:0001973) | 1.93904671 |
| 124 | Fetal akinesia sequence (HP:0001989) | 1.91165558 |
| 125 | Diminished motivation (HP:0000745) | 1.90948102 |
| 126 | Cervical subluxation (HP:0003308) | 1.90863175 |
| 127 | Hypercortisolism (HP:0001578) | 1.90755641 |
| 128 | Spastic gait (HP:0002064) | 1.90157236 |
| 129 | Annular pancreas (HP:0001734) | 1.90050464 |
| 130 | Cholecystitis (HP:0001082) | 1.89892649 |
| 131 | Abnormal gallbladder physiology (HP:0012438) | 1.89892649 |
| 132 | Peripheral demyelination (HP:0011096) | 1.89597876 |
| 133 | Gait ataxia (HP:0002066) | 1.88866039 |
| 134 | Hypsarrhythmia (HP:0002521) | 1.88762658 |
| 135 | Abnormality of the motor neurons (HP:0002450) | 1.86618954 |
| 136 | Abnormal neuron morphology (HP:0012757) | 1.86618954 |
| 137 | Abnormality of complement system (HP:0005339) | 1.85555559 |
| 138 | Joint stiffness (HP:0001387) | 1.85548355 |
| 139 | Thoracic kyphosis (HP:0002942) | 1.85306758 |
| 140 | Limb dystonia (HP:0002451) | 1.85175618 |
| 141 | Ventricular fibrillation (HP:0001663) | 1.84753464 |
| 142 | Metaphyseal irregularity (HP:0003025) | 1.82586716 |
| 143 | Rapidly progressive (HP:0003678) | 1.81142072 |
| 144 | Achilles tendon contracture (HP:0001771) | 1.80571595 |
| 145 | Hepatosplenomegaly (HP:0001433) | 1.79870676 |
| 146 | Urinary incontinence (HP:0000020) | 1.79232085 |
| 147 | Cardiomegaly (HP:0001640) | 1.77822904 |
| 148 | Bone pain (HP:0002653) | 1.73106494 |
| 149 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.71146615 |
| 150 | Thin bony cortex (HP:0002753) | 1.65282721 |
| 151 | Mediastinal lymphadenopathy (HP:0100721) | 1.64835088 |
| 152 | Increased serum ferritin (HP:0003281) | 1.63539716 |
| 153 | Turricephaly (HP:0000262) | 1.60254312 |
| 154 | Global brain atrophy (HP:0002283) | 1.60019752 |
| 155 | Memory impairment (HP:0002354) | 1.59516580 |
| 156 | Xanthomatosis (HP:0000991) | 1.59504140 |
| 157 | Hematochezia (HP:0002573) | 1.56110164 |
| 158 | Delusions (HP:0000746) | 1.55309526 |
| 159 | Hammertoe (HP:0001765) | 1.55152185 |
| 160 | Abnormality of the Achilles tendon (HP:0005109) | 1.54914293 |
| 161 | Protuberant abdomen (HP:0001538) | 1.54738222 |
| 162 | Hyperacusis (HP:0010780) | 1.53769149 |
| 163 | Distal lower limb amyotrophy (HP:0008944) | 1.52947765 |
| 164 | Mesangial abnormality (HP:0001966) | 1.51161824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.46407253 |
| 2 | NTRK3 | 4.00116191 |
| 3 | MAP3K9 | 3.50558136 |
| 4 | DAPK2 | 3.48058346 |
| 5 | CASK | 3.33454464 |
| 6 | MAP3K12 | 3.07857655 |
| 7 | RIPK4 | 2.85563854 |
| 8 | IRAK3 | 2.84064575 |
| 9 | TESK1 | 2.83602660 |
| 10 | DDR2 | 2.63311152 |
| 11 | NME2 | 2.59528524 |
| 12 | RIPK1 | 2.58165490 |
| 13 | MAP3K4 | 2.57856521 |
| 14 | MAP2K7 | 2.53629560 |
| 15 | MAP3K11 | 2.44167294 |
| 16 | DAPK1 | 2.36757759 |
| 17 | ARAF | 2.19089238 |
| 18 | MINK1 | 2.12756157 |
| 19 | KSR2 | 2.08759206 |
| 20 | CDK19 | 2.04501604 |
| 21 | PIM2 | 2.01146919 |
| 22 | ERN1 | 2.00247245 |
| 23 | CAMKK1 | 1.98813490 |
| 24 | LIMK1 | 1.98713768 |
| 25 | PAK6 | 1.94690928 |
| 26 | PLK2 | 1.94635397 |
| 27 | TESK2 | 1.87456426 |
| 28 | TAOK2 | 1.85531442 |
| 29 | PRKD3 | 1.84743153 |
| 30 | TGFBR2 | 1.84575514 |
| 31 | PRPF4B | 1.80515147 |
| 32 | TRIB3 | 1.65597030 |
| 33 | NTRK2 | 1.63672717 |
| 34 | CAMKK2 | 1.61503148 |
| 35 | NTRK1 | 1.61109831 |
| 36 | MAP2K4 | 1.60824901 |
| 37 | GRK5 | 1.58634816 |
| 38 | MAP3K13 | 1.52642238 |
| 39 | MARK1 | 1.52327185 |
| 40 | MATK | 1.51261616 |
| 41 | BLK | 1.50981349 |
| 42 | TBK1 | 1.47680652 |
| 43 | ABL2 | 1.44968358 |
| 44 | EPHB2 | 1.43320583 |
| 45 | CDK5 | 1.42359973 |
| 46 | FES | 1.41592543 |
| 47 | CDC42BPA | 1.29452788 |
| 48 | KSR1 | 1.27530621 |
| 49 | MAP3K2 | 1.27088260 |
| 50 | PDGFRA | 1.26868468 |
| 51 | CAMK1D | 1.26170313 |
| 52 | ICK | 1.21682027 |
| 53 | CCNB1 | 1.20173926 |
| 54 | PRKCG | 1.19478802 |
| 55 | PRKCH | 1.18652605 |
| 56 | MAP3K3 | 1.16961128 |
| 57 | AKT3 | 1.14558686 |
| 58 | LATS2 | 1.12163701 |
| 59 | PTK2B | 1.06987730 |
| 60 | MARK2 | 1.06670837 |
| 61 | SIK3 | 1.06325273 |
| 62 | BMPR2 | 1.04132842 |
| 63 | STK38 | 1.03085999 |
| 64 | PAK4 | 1.03048685 |
| 65 | EPHA3 | 1.01233674 |
| 66 | TAOK1 | 0.99265574 |
| 67 | SIK2 | 0.95808580 |
| 68 | DYRK1B | 0.95573677 |
| 69 | DAPK3 | 0.93374901 |
| 70 | SIK1 | 0.91783613 |
| 71 | MAP3K14 | 0.91051195 |
| 72 | BCKDK | 0.90955473 |
| 73 | CAMK2A | 0.90915523 |
| 74 | EPHB1 | 0.85512128 |
| 75 | MAP3K1 | 0.84620331 |
| 76 | SGK223 | 0.81569494 |
| 77 | SGK494 | 0.81569494 |
| 78 | TYK2 | 0.81032706 |
| 79 | OXSR1 | 0.80676830 |
| 80 | CDK18 | 0.80582303 |
| 81 | SGK2 | 0.80343286 |
| 82 | CAMK1 | 0.77922870 |
| 83 | SGK3 | 0.76707514 |
| 84 | RAF1 | 0.76355648 |
| 85 | CDK15 | 0.75657448 |
| 86 | PDK1 | 0.75605378 |
| 87 | MAP3K5 | 0.74596048 |
| 88 | CSNK1G3 | 0.73589583 |
| 89 | MAPK13 | 0.73509473 |
| 90 | PDPK1 | 0.73437901 |
| 91 | BRAF | 0.72874346 |
| 92 | CDK14 | 0.72060803 |
| 93 | TNK2 | 0.71655785 |
| 94 | CSK | 0.70500183 |
| 95 | CSNK1G2 | 0.70276425 |
| 96 | PRKD2 | 0.67642421 |
| 97 | CAMK2B | 0.66099790 |
| 98 | CSNK1A1L | 0.65623475 |
| 99 | FGR | 0.65505680 |
| 100 | MAP2K3 | 0.64668212 |
| 101 | CDK11A | 0.63472111 |
| 102 | RET | 0.62199785 |
| 103 | UHMK1 | 0.60667065 |
| 104 | STK11 | 0.58231093 |
| 105 | CAMK1G | 0.57744635 |
| 106 | MAP3K6 | 0.57664013 |
| 107 | ZAP70 | 0.57558580 |
| 108 | PRKCE | 0.57480394 |
| 109 | TTN | 0.57418790 |
| 110 | SGK1 | 0.56362899 |
| 111 | CSF1R | 0.55593447 |
| 112 | PKN1 | 0.53357719 |
| 113 | TYRO3 | 0.53317679 |
| 114 | MAP2K1 | 0.52779112 |
| 115 | TNIK | 0.52606720 |
| 116 | GRK7 | 0.52393049 |
| 117 | MAPK4 | 0.52151628 |
| 118 | IKBKB | 0.50968057 |
| 119 | FYN | 0.50386366 |
| 120 | MOS | 0.49365031 |
| 121 | NME1 | 0.48605320 |
| 122 | RPS6KC1 | 0.47761325 |
| 123 | RPS6KL1 | 0.47761325 |
| 124 | MAP2K6 | 0.47010838 |
| 125 | PINK1 | 0.46758717 |
| 126 | WNK3 | 0.46139375 |
| 127 | JAK1 | 0.45524087 |
| 128 | SYK | 0.44399756 |
| 129 | IRAK2 | 0.44333150 |
| 130 | JAK2 | 0.42770874 |
| 131 | TSSK6 | 0.42211093 |
| 132 | CAMK4 | 0.41729264 |
| 133 | ALK | 0.41579741 |
| 134 | FER | 0.40596993 |
| 135 | RPS6KA2 | 0.40276584 |
| 136 | ADRBK2 | 0.36610070 |
| 137 | NEK6 | 0.36332412 |
| 138 | RPS6KA3 | 0.35498781 |
| 139 | CAMK2G | 0.34563558 |
| 140 | MAPK7 | 0.34514253 |
| 141 | PRKCZ | 0.33462518 |
| 142 | BMX | 0.33375428 |
| 143 | ADRBK1 | 0.33147527 |
| 144 | LMTK2 | 0.32833788 |
| 145 | PAK3 | 0.32802947 |
| 146 | SCYL2 | 0.31639365 |
| 147 | CAMK2D | 0.30981035 |
| 148 | PRKCA | 0.30039571 |
| 149 | DYRK1A | 0.27645290 |
| 150 | PDK2 | 0.27200358 |
| 151 | PHKG2 | 0.27149176 |
| 152 | PHKG1 | 0.27149176 |
| 153 | PRKCB | 0.26332858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.11470053 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.20165362 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.07440451 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.94460934 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.67286461 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.34900333 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.31550093 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.30083378 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.29171776 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19108063 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.17435952 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.99431997 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.98337472 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.96387133 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.85782076 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.84657895 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.80574800 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70907261 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.63940149 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.61007713 |
| 21 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.54953038 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.53532194 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.50432769 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.48586171 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.48586014 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.39731088 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.38951137 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38338467 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.36584038 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.35840396 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.34805813 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.29832214 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.29644254 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.26920805 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.21955199 |
| 36 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20200473 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19969619 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18545231 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18227482 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18054220 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14507289 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.14092300 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12688390 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11633115 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09943574 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08119403 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05431748 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04349068 |
| 49 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03122909 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 1.02828934 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 1.02744015 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98095419 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97754795 |
| 54 | Glioma_Homo sapiens_hsa05214 | 0.96202637 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.92690261 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87889946 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86003012 |
| 58 | Bladder cancer_Homo sapiens_hsa05219 | 0.85767605 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.85702300 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.82666828 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82341595 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80840396 |
| 63 | Asthma_Homo sapiens_hsa05310 | 0.80155516 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77468967 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76885231 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75470952 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75174085 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73513320 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72802977 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71554660 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.69288017 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68915376 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.68099545 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67998009 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.67828469 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67816697 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67383155 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67117148 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66975746 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66742290 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66080438 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.65986716 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64952744 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64923355 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63060513 |
| 86 | Axon guidance_Homo sapiens_hsa04360 | 0.62592318 |
| 87 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62066919 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60778294 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58227134 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57584014 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56011833 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55087119 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55067037 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54840839 |
| 95 | Allograft rejection_Homo sapiens_hsa05330 | 0.54542950 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54499697 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.54218461 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53202029 |
| 99 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.52362779 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52322770 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.52018539 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50170600 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49983350 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48766108 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48144481 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.47523266 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47234197 |
| 108 | Phototransduction_Homo sapiens_hsa04744 | 0.46157173 |
| 109 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45926976 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45851165 |
| 111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45396023 |
| 112 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44588815 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44549738 |
| 114 | Influenza A_Homo sapiens_hsa05164 | 0.44053139 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43713276 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42715885 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41167853 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41136376 |
| 119 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.41132983 |
| 120 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40375855 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40149185 |
| 122 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.40034976 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39868224 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39802372 |
| 125 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38160866 |
| 126 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38100213 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37189108 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36756457 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.36585578 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36258999 |
| 131 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35397424 |
| 132 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.34403335 |
| 133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34054894 |
| 134 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.33288707 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32764941 |
| 136 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32682298 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32520304 |
| 138 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.32405281 |
| 139 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31826139 |
| 140 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31399290 |
| 141 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.31314654 |
| 142 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30796283 |
| 143 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30624028 |
| 144 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29264670 |

